24 results
424B5
INM
InMed Pharmaceuticals Inc
3 Jun 22
Prospectus supplement for primary offering
9:45pm
global anti-corruption and anti-bribery laws could subject us to penalties and other adverse consequences
The FCPA and the CFPOA, as well as any other … applicable domestic or foreign anti-corruption or anti-bribery laws to which we are or may become subject generally prohibit corporations
424B3
INM
InMed Pharmaceuticals Inc
25 Apr 22
Prospectus supplement
5:02pm
of Foreign Public Officials Act, or “CFPOA”, and other global anti-corruption and anti-bribery laws could subject us to penalties and other adverse … consequences.
The FCPA and the CFPOA, as well as any other applicable domestic or foreign anti-corruption or anti-bribery laws to which we are or may
424B3
INM
InMed Pharmaceuticals Inc
7 Apr 22
Prospectus supplement
4:46pm
, or “CFPOA”, and other global anti-corruption and anti-bribery laws could subject us to penalties and other adverse consequences
The FCPA and the CFPOA … , as well as any other applicable domestic or foreign anti-corruption or anti-bribery laws to which we are or may become subject generally prohibit
S-3
m8gubgrrfnlt
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
7qyy57lzegdqhygj3s
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
j28dq8ihw
24 Sep 21
Annual report
7:31am
10-K
d9f48x9ahjzw828pcy
24 Sep 21
Annual report
7:31am
424B3
gymaoz0 qa0
22 Jul 21
Prospectus supplement
10:27am
424B3
6wudh2 48uds
16 Mar 21
Prospectus supplement
12:00am
10-Q
2pyw62bsp
17 Dec 20
Quarterly report
12:00am
424B4
40dipo95qf2pvx
13 Nov 20
Prospectus supplement with pricing info
8:52pm